Literature DB >> 22733758

Quantitative assessment of the impact of the gut microbiota on lysine epsilon-acetylation of host proteins using gnotobiotic mice.

Gabriel M Simon1, Jiye Cheng, Jeffrey I Gordon.   

Abstract

The gut microbiota influences numerous aspects of human biology. One facet that has not been thoroughly explored is its impact on the host proteome. We hypothesized that the microbiota may produce certain of its effects through covalent modification of host proteins. We focused on protein lysine ε-acetylation because of its recently discovered roles in regulation of cell metabolism, and the potential for products of microbial fermentation to interact with the lysine acetylation machinery of host cells. Germ-free mice, fed a (15)N-labeled diet for two generations, were colonized as adults with a microbiota harvested from conventionally raised mouse donors. Using high-resolution mass spectrometry, we quantified 3,891 liver and proximal colonic proteins, 558 of which contained 1,602 sites of lysine acetylation, 43% not previously described. Multiple proteins from multiple subcellular compartments underwent microbiota-associated increases in their levels of lysine acetylation at one or more residues, in one or both tissues. Acetylated proteins were enriched in functions related to energy production, respiration, and primary metabolism. A number of the acetylation events affect lysine residues at or near the active sites of enzymes, whereas others occur at locations that may affect other facets of protein function. One of these modifications, affecting Lys292 in mouse α-1-antitrypsin, was detected in the corresponding lysine of the human serum protein. Methods described in this report can be applied to other co- or posttranslational modifications, and add quantitation of protein expression and covalent modification to the arsenal of techniques for characterizing the dynamic, important interactions between gut symbionts and their hosts.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22733758      PMCID: PMC3396494          DOI: 10.1073/pnas.1208669109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling.

Authors:  Christoph Reinhardt; Mattias Bergentall; Thomas U Greiner; Florence Schaffner; Gunnel Ostergren-Lundén; Lars C Petersen; Wolfram Ruf; Fredrik Bäckhed
Journal:  Nature       Date:  2012-03-11       Impact factor: 49.962

Review 2.  Comprehensive lysine acetylomes emerging from bacteria to humans.

Authors:  Go-Woon Kim; Xiang-Jiao Yang
Journal:  Trends Biochem Sci       Date:  2010-11-12       Impact factor: 13.807

Review 3.  Understanding the role of gut microbiome-host metabolic signal disruption in health and disease.

Authors:  Elaine Holmes; Jia V Li; Thanos Athanasiou; Hutan Ashrafian; Jeremy K Nicholson
Journal:  Trends Microbiol       Date:  2011-06-22       Impact factor: 17.079

4.  Induction of colonic regulatory T cells by indigenous Clostridium species.

Authors:  Koji Atarashi; Takeshi Tanoue; Tatsuichiro Shima; Akemi Imaoka; Tomomi Kuwahara; Yoshika Momose; Genhong Cheng; Sho Yamasaki; Takashi Saito; Yusuke Ohba; Tadatsugu Taniguchi; Kiyoshi Takeda; Shohei Hori; Ivaylo I Ivanov; Yoshinori Umesaki; Kikuji Itoh; Kenya Honda
Journal:  Science       Date:  2010-12-23       Impact factor: 47.728

5.  Correct interpretation of comprehensive phosphorylation dynamics requires normalization by protein expression changes.

Authors:  Ronghu Wu; Noah Dephoure; Wilhelm Haas; Edward L Huttlin; Bo Zhai; Mathew E Sowa; Steven P Gygi
Journal:  Mol Cell Proteomics       Date:  2011-05-07       Impact factor: 5.911

6.  AT-1 is the ER membrane acetyl-CoA transporter and is essential for cell viability.

Authors:  Mary Cabell Jonas; Mariana Pehar; Luigi Puglielli
Journal:  J Cell Sci       Date:  2010-09-07       Impact factor: 5.285

7.  Stability and robustness of human metabolic phenotypes in response to sequential food challenges.

Authors:  Silke S Heinzmann; Claire A Merrifield; Serge Rezzi; Sunil Kochhar; John C Lindon; Elaine Holmes; Jeremy K Nicholson
Journal:  J Proteome Res       Date:  2011-12-16       Impact factor: 4.466

8.  Human metabolic phenotype diversity and its association with diet and blood pressure.

Authors:  Elaine Holmes; Ruey Leng Loo; Jeremiah Stamler; Magda Bictash; Ivan K S Yap; Queenie Chan; Tim Ebbels; Maria De Iorio; Ian J Brown; Kirill A Veselkov; Martha L Daviglus; Hugo Kesteloot; Hirotsugu Ueshima; Liancheng Zhao; Jeremy K Nicholson; Paul Elliott
Journal:  Nature       Date:  2008-04-20       Impact factor: 49.962

9.  Quantitative reactivity profiling predicts functional cysteines in proteomes.

Authors:  Eranthie Weerapana; Chu Wang; Gabriel M Simon; Florian Richter; Sagar Khare; Myles B D Dillon; Daniel A Bachovchin; Kerri Mowen; David Baker; Benjamin F Cravatt
Journal:  Nature       Date:  2010-11-17       Impact factor: 49.962

10.  Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.

Authors:  Zeneng Wang; Elizabeth Klipfell; Brian J Bennett; Robert Koeth; Bruce S Levison; Brandon Dugar; Ariel E Feldstein; Earl B Britt; Xiaoming Fu; Yoon-Mi Chung; Yuping Wu; Phil Schauer; Jonathan D Smith; Hooman Allayee; W H Wilson Tang; Joseph A DiDonato; Aldons J Lusis; Stanley L Hazen
Journal:  Nature       Date:  2011-04-07       Impact factor: 49.962

View more
  17 in total

1.  Multi-omics Comparative Analysis Reveals Multiple Layers of Host Signaling Pathway Regulation by the Gut Microbiota.

Authors:  Nathan P Manes; Natalia Shulzhenko; Arthur G Nuccio; Sara Azeem; Andrey Morgun; Aleksandra Nita-Lazar
Journal:  mSystems       Date:  2017-10-24       Impact factor: 6.496

2.  Characterizing Sirtuin 3 Deacetylase Affinity for Aldehyde Dehydrogenase 2.

Authors:  Peter S Harris; Joe D Gomez; Donald S Backos; Kristofer S Fritz
Journal:  Chem Res Toxicol       Date:  2017-03-01       Impact factor: 3.739

Review 3.  Epigenomic regulation of host-microbiota interactions.

Authors:  Theresa Alenghat; David Artis
Journal:  Trends Immunol       Date:  2014-10-22       Impact factor: 16.687

Review 4.  The human microbiome is a source of therapeutic drug targets.

Authors:  Bret D Wallace; Matthew R Redinbo
Journal:  Curr Opin Chem Biol       Date:  2013-05-13       Impact factor: 8.822

Review 5.  The growing landscape of lysine acetylation links metabolism and cell signalling.

Authors:  Chunaram Choudhary; Brian T Weinert; Yuya Nishida; Eric Verdin; Matthias Mann
Journal:  Nat Rev Mol Cell Biol       Date:  2014-08       Impact factor: 94.444

Review 6.  Regulation of cardiac proteasomes by ubiquitination, SUMOylation, and beyond.

Authors:  Ziyou Cui; Sarah B Scruggs; Jennifer E Gilda; Peipei Ping; Aldrin V Gomes
Journal:  J Mol Cell Cardiol       Date:  2013-10-17       Impact factor: 5.000

Review 7.  Mechanisms and Dynamics of Protein Acetylation in Mitochondria.

Authors:  Josue Baeza; Michael J Smallegan; John M Denu
Journal:  Trends Biochem Sci       Date:  2016-01-25       Impact factor: 13.807

Review 8.  An evolving perspective about the origins of childhood undernutrition and nutritional interventions that includes the gut microbiome.

Authors:  Tahmeed Ahmed; David Auble; James A Berkley; Robert Black; Philip P Ahern; Muttaquina Hossain; Andrea Hsieh; Santhia Ireen; Mandana Arabi; Jeffrey I Gordon
Journal:  Ann N Y Acad Sci       Date:  2014-08-12       Impact factor: 5.691

9.  The antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse.

Authors:  Andrew P Morgan; James J Crowley; Randal J Nonneman; Corey R Quackenbush; Cheryl N Miller; Allison K Ryan; Molly A Bogue; Sur Herrera Paredes; Scott Yourstone; Ian M Carroll; Thomas H Kawula; Maureen A Bower; R Balfour Sartor; Patrick F Sullivan
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

10.  HDAC1 and HDAC2 restrain the intestinal inflammatory response by regulating intestinal epithelial cell differentiation.

Authors:  Naomie Turgeon; Mylène Blais; Julie-Moore Gagné; Véronique Tardif; François Boudreau; Nathalie Perreault; Claude Asselin
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.